Role of TFEB in parkinson’s disease: pathophysiological insights and therapeutic approaches

Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, Settembre C. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nature cell biology. 2015;17(3):288–99. https://doi.org/10.1038/ncb3114.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koprich JB, Kalia LV, Brotchie JM. Animal models of α‑synucleinopathy for Parkinson disease drug development. Nature Reviews Neuroscience. 2017;18(9):515–29. https://doi.org/10.1038/nrn.2017.75.

Article  CAS  PubMed  Google Scholar 

Wang C, Niederstrasser H, Douglas PM, Lin R, Jaramillo J, Li Y, Oswald NW, Zhou A, McMillan EA, Mendiratta S, Wang Z. Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan. Nat Commun. 2017;8(1)2270. https://doi.org/10.1038/s41467-017-02332-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santulli G, Totary-Jain H. Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics. 2013;14(12):1517–26. https://doi.org/10.2217/pgs.13.143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhuang XX, Wang SF, Tan Y, Song JX, Zhu Z, Wang ZY, Wu MY, Cai CZ, Huang ZJ, Tan JQ, Su HX. Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson’s disease models. Cell Death Discov. 2020;11(2)128. https://doi.org/10.1038/s41419-020-2322-6.

Article  CAS  Google Scholar 

Singh B, Mahajan S, Abdella S, Khan R, Garg S. Exploring autophagy inducing molecules: targeting diverse pathways in alzheimer’s disease management. Med Res Rev. 2025; https://doi.org/10.1002/med.70013.

Article  PubMed  PubMed Central  Google Scholar 

Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, Settembre C. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nature cell biology. 2015;17(3):288–99. https://doi.org/10.1038/ncb3114.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Gong S, Zhang H, Chen Y, Liu Y, Hao J, Liu H, Li X. From the regulatory mechanism of TFEB to its therapeutic implications. Cell Death Discov. 2024;10(1):84–84. https://doi.org/10.1038/s41420-024-01850-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui M, Yamano K, Yamamoto K, Yamamoto-Imoto H, Minami S, Yamamoto T, Matsui S, Kaminishi T, Shima T, Ogura M, Tsuchiya M. HKDC1, a target of TFEB, is essential to maintain both mitochondrial and lysosomal homeostasis, preventing cellular senescence. PNAS Nexus. 2024;121(2)e2306454120. https://doi.org/10.1073/pnas.2306454120.

Article  CAS  Google Scholar 

Torra A, Parent A, Cuadros T, Rodríguez-Galván B, Ruiz-Bronchal E, Ballabio A, Bortolozzi A, Vila M, Bové J. Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents Parkinson’s disease-related neurodegeneration. Mol Ther. 2018;26(6):1552–67. https://doi.org/10.1016/j.ymthe.2018.02.022.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su CJ, Shen Z, Cui RX, Huang Y, Xu DL, Zhao FL, Pan J, Shi AM, Liu T, Yu YL. Thioredoxin-interacting protein (TXNIP) regulates Parkin/PINK1-mediated mitophagy in dopaminergic neurons under high-glucose conditions: implications for molecular links between Parkinson’s disease and diabetes. Neurosci Bull. 2020;36(4):346–58. https://doi.org/10.1007/s12264-019-00459-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franco-Juárez B, Coronel-Cruz C, Hernández-Ochoa B, Gómez-Manzo S, Cárdenas-Rodríguez N, Arreguin-Espinosa R, Bandala C, Canseco-Ávila LM, Ortega-Cuellar D. TFEB; beyond its role as an autophagy and lysosomes regulator. Cells. 2022;11(19)3153. https://doi.org/10.3390/cells11193153.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moors TE, Hoozemans JJ, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC, Van De Berg WD. Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease. Mol Neurodegener. 2017;12(1)11. https://doi.org/10.1186/s13024-017-0154-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raben N, Puertollano R. TFEB and TFE3: linking lysosomes to cellular adaptation to stress. Annual review of cell and developmental biology. 2016;32(1):255–78. https://doi.org/10.1146/annurev-cellbio-111315-125407.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sahoo S, Padhy AA, Kumari V, Mishra P. Role of ubiquitin–proteasome and autophagy-lysosome pathways in α‑synuclein aggregate clearance. Mol Neurobiol. 2022;59(9):5379–407. https://doi.org/10.1007/s12035-022-02897-1.

Article  CAS  PubMed  Google Scholar 

Pinheiro PD, Diniz LP, Franco LS, Siqueira M, Gomes FC. Histone Deacetylases in Neurodegenerative Diseases and Their Potential Role as Therapeutic Targets: Shedding Light on Astrocytes. Pharmaceuticals. 2025;18(10)1471. https://doi.org/10.3390/ph18101471.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torra A, Parent A, Cuadros T, Rodríguez-Galván B, Ruiz-Bronchal E, Ballabio A, Bortolozzi A, Vila M, Bové J. Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents Parkinson’s disease-related neurodegeneration. Mol Ther. 2018;26(6):1552–67. https://doi.org/10.1016/j.ymthe.2018.02.022.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song TT, Cai RS, Hu R, Xu YS, Qi BN, Xiong YA. The important role of TFEB in autophagy-lysosomal pathway and autophagy-related diseases: a systematic review. European Review for Medical Pharmacological Sciences. 2021; https://doi.org/10.26355/eurrev_202102_24875.

Article  PubMed  Google Scholar 

Zwakenberg S, Westland D, van Es RM, Rehmann H, Anink J, Ciapaite J, Bosma M, Stelloo E, Liv N, Alcaraz PS, Verhoeven-Duif NM. mTORC1 restricts TFE3 activity by auto-regulating its presence on lysosomes. Mol Cell. 2024;84(22):4368–84. https://doi.org/10.1016/j.molcel.2024.10.009.

Article  CAS  PubMed  Google Scholar 

Corà D, Bussolino F, Doronzo G. TFEB signalling-related MicroRNAs and autophagy. Biomolecules. 2021;11(7)985. https://doi.org/10.3390/biom11070985.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ballabio A, Bonifacino JS. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. 2020; https://doi.org/10.1038/s41580-019-0185-4.

Article  PubMed  Google Scholar 

Bayati A, McPherson PS. alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions. J Biol Chem. 2024;107742. https://doi.org/10.1016/j.jbc.2024.1077422.

Brady OA, Martina JA, Puertollano R. Emerging roles for TFEB in the immune response and inflammation. Autophagy Rep. 2018;14(2):181–9. https://doi.org/10.1080/15548627.2017.13139433.

Article  CAS  PubMed  Google Scholar 

Bridi JC, Hirth F. Mechanisms of α‑synuclein-induced synaptopathy in Parkinson’s disease. Front Neurosci. 2018;12:80. https://doi.org/10.3389/fnins.2018.000800.

Article  PubMed  PubMed Central  Google Scholar 

Buratta S, Tancini B, Sagini K, Delo F, Chiaradia E, Urbanelli L, Emiliani C. Lysosomal exocytosis, exosome release and secretory autophagy: the autophagic-and endo-lysosomal systems go extracellular. International Journal of Molecular Sciences. 2020;21(7)2576. https://doi.org/10.3390/ijms21072576.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao B, Chen X, Li Y, Zhou T, Chen N, Guo Y, Zhao M, Guo C, Shi Y, Wang Q, Du X. PDCD4 triggers α‑synuclein accumulation and motor deficits via co-suppressing TFE3 and TFEB translation in a model of Parkinson’s disease. NPJ Parkinsons Dis. 2024;10(1)146. https://doi.org/10.1038/s41531-024-00760-99.

Article  CAS  PubMed 

Comments (0)

No login
gif